BACKGROUND: Sleep-disordered breathing (SDB) is common in pregnancy, but there are limited data on predictors. OBJECTIVES: The objective of this study was to develop predictive models of sleep-disordered breathing during pregnancy. STUDY DESIGN: Nulliparous women completed validated questionnaires to assess for symptoms related to snoring, fatigue, excessive daytime sleepiness, insomnia, and restless leg syndrome. The questionnaires included questions regarding the timing of sleep and sleep duration, work schedules (eg, shift work, night work), sleep positions, and previously diagnosed sleep disorders. Frequent snoring was defined as self-reported snoring !3 days per week. Participants underwent inhome portable sleep studies for sleep-disordered breathing assessment in early (6e15 weeks gestation) and mid pregnancy (22e31 weeks gestation). Sleep-disordered breathing was characterized by an apnea hypopnea index that included all apneas, plus hypopneas with !3% oxygen desaturation. For primary analyses, an apnea hypopnea index !5 events per hour was used to define sleep-disordered breathing. Odds ratios and 95% confidence intervals were calculated for predictor variables. Predictive ability of the logistic models was estimated with area under the receiver-operating-characteristic curves, along with sensitivities, specificities, and positive and negative predictive values and likelihood ratios.
S
leep-disordered breathing (SDB), predominantly obstructive sleep apnea, occurs in 10e32% of pregnancies (varying with population, diagnostic method, and definition of SDB). [1] [2] [3] SDB is a risk factor for pregnancy-related complications that include gestational hypertension, preeclampsia, and gestational diabetes mellitus. [4] [5] [6] The presence of SDB is also associated with an increased risk for cardiomyopathy, venous thromboembolism, anesthetic complications, severe maternal morbidity, and maternal death. 7 Neonatal complications such as growth restriction 8, 9 and preterm delivery 10 are also increased. Therefore, there is considerable interest in identifying pregnant women with SDB.
SDB is challenging to identify, even in a general population, because of limited specificity of SDB symptoms. 11 Women are less likely than men to report sleepiness as a symptom and are more likely to report fatigue and insomnia. 11, 12 Questionnaires that have been validated in the general population are poorly predictive in pregnant women. 2, 13 Although overnight polysomnography is the gold standard for diagnosis, the cost and inconvenience preclude widespread use.
14 Thus, it is desirable to identify pregnant women who are at increased risk for SDB before obtaining such polysomnographic information.
A number of studies have attempted to identify predictors of SDB in pregnancy. These studies have been limited by their sample size, limited study population, or method of testing for SDB. 3, 15 In this study, we sought to develop clinically feasible prediction models for SDB in a large cohort of nulliparous pregnant women who underwent objective testing for SDB.
Methods
Participants in this study were enrolled in the Sleep-Disordered Breathing Substudy of the Nulliparous Pregnancy Outcomes: Monitoring Mothers-to-Be (nuMoM2b) study. Details of the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be parent 16 and Sleep-Disordered Breathing Substudy methods have been published previously. 17 For the nuMoM2b parent study, which was managed by an independent data-coordinating center, women were recruited at 8 clinical sites.
Women were eligible for participation in the parent study if they were nulliparous (no previous delivery at !20 weeks of gestation) and had a viable singleton pregnancy at the time of screening (6e13 6 weeks of gestation). Participants from the parent study were offered enrollment into the SleepDisordered Breathing Substudy. The primary aim of the sleep substudy was to evaluate SDB during pregnancy as a risk factor for the development of hypertensive disorders of pregnancy and gestational diabetes mellitus. 5 Women were excluded for the following conditions: current SDB that was being treated with continuous positive airway pressure therapy, severe asthma that required continuous oral steroid therapy for >14 days, or a condition that required oxygen supplementation. After enrollment, participants received routine prenatal care. During study visits, trained research coordinators obtained longitudinal clinical measurements per protocol. 17 
Questionnaires
Sleep questionnaires were completed by all participants in the parent study at the first (6e13 6 weeks of gestation) and third study visits (22e29 6 weeks). These questionnaires included questions regarding the timing of sleep and sleep duration, work schedules (eg, shift work, night work), sleep positions, and previously diagnosed sleep disorders. Frequent snoring was defined as selfreported snoring !3 days per week. Questions from validated sleep questionnaires that were collected included (1) the Berlin Questionnaire (a screening instrument designed to identify adults likely to have obstructive sleep apnea through a series of questions pertaining to snoring behavior and wake-time sleepiness), 18 (2) the Epworth Sleepiness Scale (a measurement of daytime sleep propensity, that uses estimates of the likelihood of dozing off or falling asleep in 8 different sedentary situations), 19, 20 (3) the International Restless Legs Syndrome Study Group diagnostic criteria for restless legs syndrome, 21 and (4) the Women's Health Initiative Insomnia Rating Scale (quantifies insomnia symptom severity). 22, 23 Home sleep testing Participants in the nuMoM2b SleepDisordered Breathing Substudy underwent in-home sleep apnea testing with the use of a 6-channel monitor that was self-applied by the participant for a single night at 2 time points: early pregnancy at 6e15 6 weeks of gestation (within 2 weeks after nuMoM2b study visit 1) and mid pregnancy at 22e31 6 weeks of gestation (within 2 weeks after visit 3). Sleep study data were downloaded at the study site and electronically transmitted to a central sleep reading center where data were scored by individuals masked to all other study data. A description of the scoring and qualitycontrol protocol has been published previously. 17 Sleep studies were scored with the alternative definitions of the American Academy of Sleep Medicine. 24 SDB was characterized with an apnea hypopnea index (AHI) that included all apneas, plus hypopneas with !3% oxygen desaturation
Statistical analysis
AHI was analyzed as a dichotomous variable; an AHI of !5 defined SDB. 25 Separate models were developed to predict the following outcomes: (1) SDB at visit 1, (2) SDB at visit 3, and (3) new-onset SDB at visit 3 for those without SDB at visit 1. Eightysix potential predictors of interest were specified a priori and are summarized in the Supplement. These were determined by a review of the published literature in the pregnant and nonpregnant populations, and were included if they were considered wellestablished risk factors. 1, 14, [26] [27] [28] The potential predictors of interest were further evaluated by the members of the writing group that included experts in sleep medicine (P.C.Z., S.R.), maternal fetal medicine (J.M.L., F.L.F., R.M.S.), biostatistics (M.A.K., B.C., C.B.P.). Sixteen candidate variables for predictive modeling were selected from the potential predictors of interest based on the writing group's consensus and statistical factors: P<.15 for association with SDB for at least 1 outcome, magnitude of observed odds ratios, avoidance of sparse numbers of SDB events in predictor response categories (where pooling was not possible) for each outcome, avoidance of potential collinearity among predictor variables, and ease and reliability of measurement in a clinical setting. Chosen candidate predictors are shown in Tables 1 and 2 , which are subset from the Supplement.
Forward selection with the use of logistic regression with a probability value of <.15 to enter was used to reduce the candidate list for each outcome. Among candidate predictors, body mass index (BMI), systolic blood pressure, and frequent snoring were collected at both visits 1 and 3. Of these, only the values measured through visit 1 were used to model SDB at visit 1; for visit 3 predictions, we used only the visit 3 measurements to avoid potential collinearity with measurements from visit 1. Also, the latter reflected the goal of identification measures that are readily available, acknowledging that many pregnant women initiate prenatal care after the visit 1 time interval and thus would not have these measurements from early pregnancy.
After forward selection, further reduction in the number of predictors was pursued to identify parsimonious and easy-to-apply models without appreciable loss of predictive performance; these reduced models contained age, BMI, and frequent snoring for each outcome. They were then examined for nonlinearity. Significant quadratic effects for BMI (P¼.0003, <.0001, <.0001) were found for visits 1 and 3 and visit 3 new-onset SDB, but their inclusion resulted in observations with undue leverage on the regression. Consequently, because BMI was highly skewed at both visits, we sought a BoxCox power transformation 29 
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The geometric means for BMI were 25.8, 28.6, and 28.3. Quadratic terms for BMI became nonsignificant (p¼.86e.37 and .11) after power transformation. Interactions for frequent snoring with transformed BMI (tBMI) and with age were nonsignificant (all P>.22), as was the main effect of weeks of gestation at the sleep assessment (all P>.20).
Calibration of the final parsimonious models was assessed with the HosmerLemeshow goodness-of-fit test. 31 The models were validated internally with 10-fold cross-validation to reduce model optimism. 32 Data for a given outcome were divided randomly into 10 subsets (folds); for a given subset, predicted probabilities were calculated based on fitting the model to the 90% not in the subset, which was repeated for each subset. These predicted probabilities were combined across subsets, and performance measures were generated. Classification was assessed with area under the curve (AUC) for the receiveroperating-characteristic curve. The following test characteristics were calculated at selected specificities: predicted probability cutoff, proportion of participants exceeding the cutoff, sensitivity, positive and negative predictive values, and positive and negative likelihood ratios.
In the logistic regression models, continuous predictors were standardized to zero mean and unit standard deviation so that resulting odds ratios pertain to a 1 standard deviation difference in the predictor. Except as otherwise stated, all tests were performed at a nominal significance level of a¼.05. All single degree-of-freedom tests were 2-sided. No correction was made for multiple comparisons. In a given regression model, participants with missing values for !1 predictors were excluded. Analyses were conducted with SAS statistical software (version 9.4; SAS Institute, Inc). This study was approved by the institutional review board at each center, and all women provided informed written consent before enrollment.
Results
Among the 10,038 participants of the nuMom2b parent study, 3705 women enrolled in the Sleep-Disordered Breathing Substudy between March 2011 and September 2013. Enrollment data are presented in Figure 1 . Among the 3704 women who attempted a visit 1 sleep study, 88.1% generated data of quality sufficient to be interpretable. 17 The visit 3 sleep study was attempted by 2868 women, and 96.6% met criteria for data. Among those with successful visit 1 studies, 3.5% had SDB. At visit 3, 8.2% had SDB, and 5.2% had newonset SDB. Among the 837 women without a visit 3 sleep study (1 participant had a visit 3 study but no visit 1 study), 65 had a preterm delivery (35 deliveries at <20 weeks of gestation and 30 deliveries at >20 weeks of gestation) before the sleep study could be completed, 137 missed the study visit (including the sleep assessment), and 635 had a visit 3 but did not choose to perform the sleep study. In planning the study, it was assumed and considered in sample size estimations that 25% of women would decline the second sleep study 13 ; thus, the participation rate in the visit 3 sleep study was greater than expected.
Descriptive statistics for candidate predictors by study visit are presented in Table 1 . Characteristics were similar between participants with sleep studies at visits 1 and 3. The prevalence of frequent snoring increased from 18.1e25.7% between visits 1 and 3.
Single-variable associations between candidate variables and SDB outcomes are presented in Table 2 . All candidate variables had significant associations with at least 1 of the 3 outcomes. (The Supplement include all the potential predictors of interest.) Table 3 shows results of forward logistic selection; visit 3 BMI, maternal age, and frequent snoring captured most of the predictive power for visit 3 SDB and new-onset visit 3 SDB, with AUCs at entry of 0.838 and 0.812. Accordingly, Original Research OBSTETRICS ajog.org they were adopted provisionally as predictors for the parsimonious models.
Age and BMI at visit 1 predicted visit 1 SDB with an AUC at entry of 0.869. We added frequent snoring at visit 1 to this provisional set for visit 1 SDB, which did not improve the AUC but provided consistency with the visit 3 models. In forward selection, participants were excluded if they were missing data in any of the candidate predictors. For these provisional models, the number of participants excluded for missing predictors was 40 (1.2%), 57 (2.2%), and 50 (2.2%) for the 3 outcomes. The provisional parsimonious models were then checked, as described in the Methods section. Each of the 2 final parsimonious models included (transformed) BMI, maternal age, and frequent snoring. AUCs were 0.875, 0.841, and 0.816, and lack of fit was nonsignificant (P¼.18, .98, and .39), which indicated reasonable calibration (lack of bias) for the regressions. Figure 2 shows 10-fold cross-validated receiver-operating-characteristic curves for the final parsimonious models. The AUCs for visits 1 and 3 and new-onset visit 3 were 0.870, 0.838, and 0.809, which were only slightly smaller than the nonvalidated AUCs. Table 4 provides 10-fold cross-validated performance statistics for these models at selected specificities. Predicted probability cutoffs that corresponded to 90% specificity were !.082 for SDB at visit 1, !.170 at visit 3, and !.128 for new onset at visit 3. Testing with the use of these cutoffs, which are each about twice the overall prevalence, would involve referring 11.8%, 13.6%, and 12.1% of patients for objective testing and would yield sensitivities of 61.1%, 54.5%, and 45.8%, respectively. 33 Testing with lower specificity would provide greater sensitivity but would involve cutoff probabilities near to or below the overall prevalence, which may be appropriate for designing a screening procedure for a clinical trial.
Integrated predictiveness and classification curves, along with orientation and illustrative examples, are found in the Supplement, which show the relationships between predicted probability cutoff, proportion of participants at or above the cutoff, and the cross-validated true positive fraction (sensitivity) and false positive fraction (1 minus specificity). 31 Also in the Supplement are expanded versions of Tables 1 and 2 , including all the potential predictors of interest, and an Excel sheet-based predicted probability calculator based on the final models, which were internally but not externally validated.
Comment
In the clinical setting, it is important to have an inexpensive, easy-to-use, and rapid tool that can be used to identify women who are at risk for SDB. We developed predictive models using only 3 variables (current maternal age, BMI, and frequent snoring) to predict objectively measured SDB in early and mid pregnancy, including new-onset SDB in mid pregnancy. These predictors are obtainable easily, assessment of frequent snoring involves the simple questions, "In the last 4 weeks, have you snored?" and if so, "Have you snored !3 times a week?"
In nuMoM2b, overnight home sleep apnea testing provided objective assessments of SDB on 3264 nulliparous pregnant women at 6e15 6 weeks of gestation (within 2 weeks after nuMoM2b study visit 1) and 2512 women at 22e31 6 weeks (within 2 weeks after visit 3).
This study is the largest to date to evaluate the risk factors prospectively for objectively measured SDB during The flowchart shows enrollment in the Sleep-Disordered Breathing Study within the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be and inclusion in modelling for prediction of sleep-disordered breathing at the study visits 1 and 3 and new onset sleep-disordered breathing at visit 3.
nuMoM2b, mothers-to-be; SDB, sleep-disordered breathing.
Louis et al. SDB predictors. Am J Obstet Gynecol 2018.
ajog.org OBSTETRICS Original Research pregnancy. As others have reported, the Berlin and Epworth Sleepiness Scales tools, which have been developed and used in the adult nonpregnant population, have low sensitivity and specificity and are poorly predictive of SDB in pregnant women. 27, 34, 35 Our model presents a simplified option for the identification of these women.
Our findings are similar to those of Facco et al, 27 who used a cohort of 100 women in early pregnancy to devise a scoring system that used 4 variables to predict SDB: chronic hypertension, age, BMI, and self-reported frequent snoring. 27 In that group, the weighted model predicted objectively-measured obstructive sleep apnea with a sensitivity of 86% (95% confidence interval, 66e95%) and a specificity of 74% (95% confidence interval, 62e83%). Our study has the added benefit of examining mid pregnancy and early pregnancy. One of the oft cited limitations of existing cross-sectional studies is the inability to differentiate between preexisting SDB detected during pregnancy and new-onset SDB in pregnancy. 27, 34 Our large sample size and longitudinal study design allowed us the opportunity to address the occurrence and predictors of newonset SDB in mid pregnancy. It is also notable that BMI and not pregnancy weight gain was predictive of SDB and new onset SDB. Although other studies were not powered to evaluated pregnancy weight gain, those findings stressed the importance of BMI as a predictor. 3, 4, 27 Pien et al 3 also found an increased prevalence of SDB over the course of pregnancy in a group of women who underwent in-laboratory polysomnography and concluded that age a Apnea hypopnea index >5, with forward selection (P<.15 to enter) for study visit 1 and 3 and new onset sleep-disordered breathing at study visit 3; frequent snoring was defined as snoring !3 days per week during the 4 weeks before the visit; b Variables not selected for sleep-disordered breathing at V1 were smoking during 3 months before pregnancy, chronic hypertension, hypothyroidism, family history of diabetes mellitus, family history of hypertension, systolic blood pressure at study visit 1, and frequent snoring in the 4 weeks before study visit 1; c Variables not selected for sleep-disordered breathing at study visit 3 were smoking during 3 months before pregnancy, chronic hypertension, family history of heart disease, family history of hypertension, neck circumference at study visit 1, and systolic blood pressure at study visit 3;
d Variables not selected for new onset sleep-disordered breathing at study visit 3 were race/ethnicity, smoking during 3 months before pregnancy, chronic hypertension, family history of heart disease, family history of hypertension, neck circumference at study visit 1, and systolic blood pressure at study visit 3. Louis et al. SDB predictors. Am J Obstet Gynecol 2018.
Original Research OBSTETRICS ajog.org and BMI were the predominant risk factors for SDB, regardless of the trimester of pregnancy. Our findings are also consistent with observations in the general population, in which the predictors of age, BMI, and frequent snoring are most predictive of SDB. 36 As in other reports, excessive daytime sleepiness, which is a traditionally reported symptom of SDB, was not predictive of SDB in this population. The sole variable that was associated with SDB was the self-reported "nodding off although driving"; however, reported numbers were small, and the associations did not meet criteria for inclusion into the candidate list. Our findings are consistent with other reports 2, 27, 34 and highlight the difficulty of the identification of SDB. 37 One exception was selfreported frequent snoring. Although most cases of SDB in early pregnancy were predicted by age and BMI, later in pregnancy the presence of self-reported frequent snoring was associated with the ascertainment of more cases of SDB. The prevalence of self-reported snoring increases over the course of pregnancy, as does the prevalence of SDB, 1,34,38 as we also found in our study. Our results agree with the findings of Shah et al, 36 who specifically examined the value of considering symptoms such as fatigue and insomnia as predictor of SDB in women; we also found that a simpler equation, including age, BMI, and snoring frequency provided the best prediction equation.
The strengths of this study are the prospective design, longitudinal assessment of exposures and outcomes in both early and mid pregnancy, and the sample size. The use of a central sleep reading center allowed for uniform interpretation of sleep data. However, when interpreting our data, a few limitations should be considered. This was a cohort of mostly young healthy women. As such, the prevalence of SDB may have been lower than in a community-based sample. Given this limitation, our model may underestimate the probability of SDB in a cohort with more multiparous and older women. Although the gold standard for diagnosis of SDB is overnight polysomnography, 39 the cost and inconvenience of laboratory overnight polysomnography testing precluded its use in such a large study. Home sleep apnea testing is an acceptable alternative for diagnosis in select populations and has been used increasingly in the general population. 39 However, because total sleep time is usually overestimated during home sleep testing and arousals precipitated by disordered breathing events are not detected (because electroencephalogram signals usually are not recorded), AHI may be underestimated. We used a cutoff of AHI !5 as abnormal, and participants underwent a single night of home sleep testing. One night of sleep may not be truly representative because there has been reported night-to-night variation in the severity of sleep apnea. 40 Furthermore, the AHI may not identify individuals with airflow limitation or Ten-fold cross-validated receiver operating characteristic curves
The plot shows the 10-fold cross-validated receiver operating characteristic curves for the final parsimonious models for the prediction of sleep-disordered breathing at study visit 1 (transformed body mass index, maternal age, and frequent snoring; area under the curve, 0.870), sleepdisordered breathing at study visit 3 (transformed body mass index, maternal age, and frequent snoring; area under the curve, 0.838), and new onset sleep-disordered breathing at the third study visit (also transformed body mass index at, maternal age, and frequent snoring at study visit 3 (area under the curve, 0.809). Body mass index was transformed with the use of a Box-Cox power transformation with l ¼ À1.25 (Methods section). Frequent snoring was defined as snoring !3 days per week during the 4 weeks before the visit. 
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upper airway resistance syndrome who, despite a low AHI score, may experience symptoms and adverse health outcomes.
In conclusion, our results demonstrate that SDB among pregnant women can be predicted in early and mid pregnancy (prevalent and incident SDB) by simple models that include current age, BMI, and self-reported frequent snoring.
Our models performed well, with AUCs >0.8. Our findings are important for the practicing clinician who seeks to identify pregnant women who are at high risk for SDB. Our findings can also help inform the screening of women for future studies of SDB in pregnancy. n
